Hepatocellular carcinoma in Hong Kong: clinical study on 340 cases.
Three hundred and forty cases of hepatocellular carcinoma in Hong Kong were studied for their clinical features, and various factors were analysed for their prognostic values. The clinical presentation was often vague and rather non-specific and a majority of patients were presented late and often unresectable. The overall median survival was 8 weeks. The Karnofsky performance scale and bilirubin level were the most important prognostic factors. The treated group survived longer than the untreated group.
Shiu
W
W
Department of Clinical Oncology, Chinese University, Hong Kong.
Dewar
G
G
Leung
N
N
Leung
W T
WT
Chan
M
M
Tao
M
M
Lui
C
C
Chan
C L
CL
Lau
W Y
WY
Metreweli
C
C
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000401:mortality* / Q000628:therapy; D005260:Female; D006509:Hepatitis B / Q000150:complications; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D008113:Liver Neoplasms / Q000209:etiology / Q000401:mortality* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015996:Survival Rate